You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 41 Next »

Project Scope

This project team will create a users guide or White Paper with recommendations for analysis and displays for Laboratory Data, with a focus on Phase 2-4 clinical trials and integrated submission documents. There have been 2 previous White Papers on this topic (1 for central tendency in 2013 and 1 for Outliers/Shifts in 2015). This paper will combine two method types and update recommendations given the advancement in interactive options. 

Project LeadsEmail
Charles Beasley (Beasley Pharmaceutical and Biotechnology Consulting)charlesmbeasleyjr@msn.com

Wei Wang (Eli Lilly)

wang_wei_v@lilly.com

Katie Warren (PHUSE Project Assistant)katie@phuse.global

Objectives & Deliverables 

Timelines 

White Paper (initial scope) 

Q3 2022

CURRENT STATUS Q2/3 2022

Final White Paper (initial scope) has been designed and is currently being reviewed by the project team before publishing. 

Project MembersOrganisation
Amelia PangSanofi
Darshan BhattIndustry
Edward RauschEli Lilly
Hongli LuMerck
Kirthi RangarajuPfizer
Mary NilssonEli Lilly
Maria DaltonGSK
Mercy NavarroGenentech
Miri Kramer Mediwound
Nancy BruckenCSG
Nhi BeasleyFDA
Raj PhadtareCorvus Pharmaceuticals
Robert (Mac) GordonJanssen Research & Development
Sumit PradhanIndustry
Shayami 

Thanabalasundrum

Eli Lilly
  • No labels